4.7 Article

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts

期刊

SCIENTIFIC REPORTS
卷 6, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/srep26027

关键词

-

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]
  2. DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]
  3. National Institute on Aging
  4. National Institute of Biomedical Imaging and Bioengineering
  5. Alzheimer's Association
  6. Alzheimer's Drug Discovery Foundation
  7. Araclon Biotech
  8. BioClinica, Inc.
  9. Biogen Idec Inc.
  10. Bristol-Myers Squibb Company
  11. Eisai Inc.
  12. Elan Pharmaceuticals, Inc.
  13. Eli Lilly and Company
  14. EuroImmun
  15. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  16. Fujirebio
  17. GE Healthcare
  18. IXICO Ltd.
  19. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  20. Johnson & Johnson Pharmaceutical Research & Development LLC.
  21. Medpace, Inc.
  22. Merck Co., Inc.
  23. Meso Scale Diagnostics, LLC.
  24. NeuroRx Research
  25. Neurotrack Technologies
  26. Novartis Pharmaceuticals Corporation
  27. Pfizer Inc.
  28. Piramal Imaging
  29. Servier
  30. Synarc Inc.
  31. Takeda Pharmaceutical Company
  32. Canadian Institutes of Health Research
  33. Northern California Institute for Research and Education
  34. National Natural Science Foundation of China [81471309, 81171209, 81371406]

向作者/读者索取更多资源

The Clusterin (CLU) gene, also known as apolipoprotein J (ApoJ), is currently the third most associated late-onset Alzheimer's disease (LOAD) risk gene. However, little was known about the possible effect of CLU genetic variants on AD pathology in brain. Here, we evaluated the interaction between 7 CLU SNPs (covering 95% of genetic variations) and the role of CLU in beta-amyloid (A beta) deposition, AD-related structure atrophy, abnormal glucose metabolism on neuroimaging and CSF markers to clarify the possible approach by that CLU impacts AD. Finally, four loci (rs11136000, rs1532278, rs2279590, rs7982) showed significant associations with the A beta deposition at the baseline level while genotypes of rs9331888 (P = 0.042) increased A beta deposition. Besides, rs9331888 was significantly associated with baseline volume of left hippocampus (P = 0.014). We then further validated the association with A beta deposition in the AD, mild cognitive impairment (MCI), normal control (NC) sub-groups. The results in sub-groups confirmed the association between CLU genotypes and A beta deposition further. Our findings revealed that CLU genotypes could probably modulate the cerebral the A beta loads on imaging and volume of hippocampus. These findings raise the possibility that the biological effects of CLU may be relatively confined to neuroimaging trait and hence may offer clues to AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Environmental Sciences

Residential greenness and risk of incident dementia: A prospective study of 375,342 participants

He-Ying Hu, Ya-Hui Ma, Yue-Ting Deng, Ya-Nan Ou, Wei Cheng, Jian-Feng Feng, Lan Tan, Jin-Tai Yu

Summary: This study found an association between residential greenness and dementia incidence, indicating that increasing greenspace can reduce the risk of dementia. The protective effect of greenness may be mediated through the reduction of particulate air pollution.

ENVIRONMENTAL RESEARCH (2023)

Article Cell Biology

Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer's disease

Xin-Xin Fu, Rui Duan, Si-Yu Wang, Qiao-Quan Zhang, Bin Wei, Ting Huang, Peng-Yu Gong, Yan E, Teng Jiang, Ying-Dong Zhang

Summary: This study found that lamotrigine treatment can improve cognitive function and pathological damage related to Alzheimer's disease. The beneficial effects may be mediated by the regulation of specific gene expression in the brain. These results suggest that lamotrigine may be a promising therapeutic drug for Alzheimer's disease.

NEURAL REGENERATION RESEARCH (2023)

Article Cell Biology

The Alzheimer's disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation

Si-Yu Wang, Xin-Xin Fu, Rui Duan, Bin Wei, Hai-Ming Cao, E. Yan, Shuai-Yu Chen, Ying-Dong Zhang, Teng Jiang

Summary: This study provides evidence that TREML2 modulates inflammation by regulating microglial polarization and NLRP3 inflammasome activation, suggesting a novel therapeutic strategy for Alzheimer's disease (AD).

NEURAL REGENERATION RESEARCH (2023)

Article Neurosciences

Clopidogrel with Aspirin versus Aspirin Alone following Intravenous Thrombolysis in Minor Stroke: A 1-Year Follow-Up Study

Hai-Ming Cao, Hui-Wen Lian, Yan E, Rui Duan, Jun-Shan Zhou, Xiang-Liang Chen, Teng Jiang

Summary: The long-term effect of dual antiplatelet therapy (DAPT) using clopidogrel plus aspirin versus aspirin monotherapy after intravenous thrombolysis on functional outcomes in patients with minor stroke was investigated. The study found that DAPT was associated with improved functional outcome at the 1-year follow-up for patients with minor stroke, without increasing the stroke recurrence rate and mortality.

BRAIN SCIENCES (2023)

Article Biology

Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas

Nirmal Verma, Gopal Viswanathan Velmurugan, Edric Winford, Han Coburn, Deepak Kotiya, Noah Leibold, Laura Radulescu, Sanda Despa, Kuey C. Chen, Linda J. Van Eldik, Peter T. Nelson, Donna M. Wilcock, Gregory A. Jicha, Ann M. Stowe, Larry B. Goldstein, David K. Powel, Jeffrey H. Walton, Manuel F. Navedo, Matthew A. Nystoriak, Andrew J. Murray, Geert Jan Biessels, Claire Troakes, Henrik Zetterberg, John Hardy, Tammaryn Lashley, Florin Despa

Summary: Impairment of vascular pathways contributes to Alzheimer's disease. Blood amylin secreted from the pancreas perturbs cerebral A beta clearance, leading to amylin and A beta co-deposits in the brain microvasculature. Altering bloodborne amylin could potentially reduce cerebrovascular amylin deposits and A beta pathology.

COMMUNICATIONS BIOLOGY (2023)

Review Clinical Neurology

A new ERBB4 variant in amyotrophic lateral sclerosis type 19: Case report and review of the literature

Na Zhang, Ke-Liang Chen, Yu-Yuan Huang, Shu-Fen Chen, Qiang Dong, Lan Tan, Jin-Tai Yu

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Article Neurosciences

Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid-soluble TREM2

Zuo-Teng Wang, Yan Fu, Shi-Dong Chen, Yu-Yuan Huang, Ya-Hui Ma, Yan-Jiang Wang, Lan Tan, Jin-Tai Yu

Summary: This study is the first to identify significant associations between TREM1 rs2062323 and AD risk. The rs2062323T may be involved in AD by regulating the expression of TREM1, TREML1, TREM2, and sTREM2. The TREM family is expected to be a potential therapeutic target for AD.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Article Clinical Neurology

Associations of Life's Simple 7 with cerebral white matter hyperintensities and microstructural integrity: UK Biobank cohort study

Yan Fu, Yan Sun, Zhi-Bo Wang, Dan-Dan Zhang, Lan Tan, Jian-Feng Feng, Wei Cheng, Jin-Tai Yu

Summary: This study used the American Heart Association's Life's Simple 7 (LS7) metric to define cardiovascular and brain health and found that ideal LS7 cardiovascular health factors are associated with both macrostructural and microstructural markers of brain health. The results suggest that better LS7 profiles are linked to better brain health.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments

Xin-Xin Fu, Bin Wei, Hai-Ming Cao, Rui Duan, Yang Deng, Hui-Wen Lian, Ying-Dong Zhang, Teng Jiang

Summary: TEL has shown promising effects in the prevention and treatment of AD. It improves cognitive and executive impairments, reduces neuronal and synaptic injury, Aβ pathology, neuroinflammation, and oxidative stress. The beneficial effects of TEL are achieved by inhibiting Aβ production and promoting Aβ degradation, as well as through its anti-inflammatory effects via microglial pathways. Early administration of TEL can also prevent the onset of AD-related symptoms.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Biochemistry & Molecular Biology

Associations of circulating metabolites with cerebral white matter hyperintensities

Yan Sun, Yu Guo, Hong-Qi Li, Lan Tan, Jian-Feng Feng, Wei Cheng, Jin-Tai Yu

Summary: White matter hyperintensities (WMH) are strongly associated with stroke, dementia, and early mortality. This study investigated the relationship between WMH and circulating metabolites in a large sample of individuals from the UK Biobank. The results showed that several metabolites, including high-density lipoprotein (HDL), fatty acids, and glycoprotein acetyls, were associated with WMH. Age and sex also had a significant influence on these associations. The findings suggest that specific metabolomic features accompany WMH and may provide insights into the implications of WMH in different populations.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Neurosciences

The TREM2 H157Y Variant Influences Microglial Phagocytosis, Polarization, and Inflammatory Cytokine Release

Xin-Xin Fu, Shuai-Yu Chen, Hui-Wen Lian, Yang Deng, Rui Duan, Ying-Dong Zhang, Teng Jiang

Summary: Previously, the H157Y variant of the TREM2 gene was found to be associated with increased risk of Alzheimer's disease (AD) in Han Chinese population. In this study, using CRISPR-Cas9-engineered BV2 microglia, researchers investigated the effect of the Trem2 H157Y variant on AD-related microglial functions. The findings showed that this variant inhibits microglial phagocytosis, promotes M1-type polarization, and enhances the release of inflammatory cytokines.

BRAIN SCIENCES (2023)

Review Clinical Neurology

A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia

Atri Chatterjee, Veronica Hirsch-Reinshagen, Imogene Scott, Neil Cashman, Ging-Yuek Robin Hsiung

Summary: This study conducted a systematic review and found that the frequency of psychosis in FTD patients was 24.2%. Among the genetic mutation carriers, C9orf72 mutation carriers had the highest frequency of psychosis (31.4%), while GRN and MAPT mutation carriers had lower frequencies of psychosis. Among the pathological subtypes, patients with FUS pathology, TDP-43 pathology, and tau pathology had a prevalence of psychosis at 30%, 25.3%, and 16.4% respectively.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2023)

Article Neurosciences

Identifying canonical and replicable multi-scale intrinsic connectivity networks in 100k+resting-state fMRI datasets

A. Iraji, Z. Fu, A. Faghiri, M. Duda, J. Chen, S. Rachakonda, T. DeRamus, P. Kochunov, B. M. Adhikari, A. Belger, J. M. Ford, D. H. Mathalon, G. D. Pearlson, S. G. Potkin, A. Preda, J. A. Turner, T. G. M. van Erp, J. R. Bustillo, K. Yang, K. Ishizuka, A. Faria, A. Sawa, K. Hutchison, E. A. Osuch, J. Theberge, C. Abbott, B. A. Mueller, D. Zhi, C. Zhuo, S. Liu, Y. Xu, M. Salman, J. Liu, Y. Du, J. Sui, T. Adali, V. D. Calhoun

Summary: This study identifies replicable multi-spatial-scale canonical intrinsic connectivity network (ICN) templates using rsfMRI data from over 100k individuals through multi-model-order independent component analysis (ICA). The feasibility of estimating subject-specific ICNs via spatially constrained ICA is also studied. The results show that subject-level ICN estimations vary as a function of the ICN itself, the data length, and the spatial resolution. Longer scans may not always be desirable and spatial smoothness should be considered in optimizing data length.

HUMAN BRAIN MAPPING (2023)

Article Biochemistry & Molecular Biology

Circulating metabolites and risk of incident dementia: A prospective cohort study

Shu-Yi Huang, Ya-Ru Zhang, Liu Yang, Yu-Zhu Li, Bang-Sheng Wu, Shi-Dong Chen, Jian-Feng Feng, Qiang Dong, Wei Cheng, Jin-Tai Yu

Summary: Identifying circulating metabolites associated with dementia, cognition, and brain volume could provide new insights into the pathogenesis of dementia. This cohort study found 26 metabolites associated with incident dementia, including specific associations with Alzheimer's disease (AD) and vascular dementia (VD). Circulating levels of certain lipoproteins were found to be associated with the risk of AD and AD phenotypes, while another lipoprotein was associated with the risk of VD.

JOURNAL OF NEUROCHEMISTRY (2023)

Article Biochemistry & Molecular Biology

The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study

Ji-Yun Cheng, Yue-Ting Deng, Jin-Tai Yu

Summary: Through a more robust analysis, we found potential associations between circulating levels of amino acids and the risk of neurodegenerative diseases. Increase in circulating levels of Glutamine (Gln) was associated with lower risk of Alzheimer's disease (AD), while increase in circulating levels of Leucine (Leu) was associated with lower risk of Parkinson's disease (PD). Replication tests further confirmed the potential association between circulating Gln levels and AD risk.

JOURNAL OF NEUROCHEMISTRY (2023)

暂无数据